Institutional Change in Clinical Trials in the era of the COVID-19 Pandemic
Journal of the Society for Clinical Data Management · 2022
DOI: 10.47912/jscdm.103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Society for Clinical Data Management, 2022. Verfasst von Tempei Miyaji und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
To understand the current phenomena of conducting clinical trials in the era of the coronavirus disease (COVID-19) and prepare for a change in conduct, it might be worth to understand the phenomena of clinical trials from the perspective of “institutional change”. This short perspective paper will describe the basic concepts of institutions and institutional change and explore expected institutional changes in clinical trials as a result of the coronavirus disease (COVID-19).
Zitieren
APA
Miyaji, T., Kiuchi,, T., & Yamaguchi, T. (2022). Institutional Change in Clinical Trials in the era of the COVID-19 Pandemic. Journal of the Society for Clinical Data Management. https://doi.org/10.47912/jscdm.103
Vancouver
Miyaji T, Kiuchi, T, Yamaguchi T. Institutional Change in Clinical Trials in the era of the COVID-19 Pandemic. Journal of the Society for Clinical Data Management. 2022. doi:10.47912/jscdm.103
BibTeX
@article{Miyaji2022,
author = {Miyaji, Tempei and Kiuchi,, Takahiro and Yamaguchi, Takuhiro},
title = {Institutional Change in Clinical Trials in the era of the COVID-19 Pandemic},
journal = {Journal of the Society for Clinical Data Management},
year = {2022},
doi = {10.47912/jscdm.103}
}
EUVIMED